CXCL3 and breast cancer: Leading-edge analysis (for genes that contributed most to enrichment in pathways) showed genes that are upregulated downstream of KRAS in lung or breast cancer (e.g., CXCL3, ADAM8, and L.I.F.) (Figure S3).